logo Cure Glomerulonephropathy Network
Picture of doctors

Cure Glomerulonephropathy (CureGN) is a multicenter five-year cohort study of glomerular disease patients funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes for Health (NIH) and NephCure Kidney International (NKI).

The CureGN project will study 2,400 children and adults with the following glomerular diseases: minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and IgA nephropathy (IGAN).

Participants will be followed longitudinally to better understand the causes of disease, response to therapy, and disease progression, with the ultimate objective to cure glomerulonephropathy.

© 2014 Arbor Research Collaborative for Health
Supported by NIH/NIDDK grant number 1UM1DK100845-01 and NephCure Kidney International Privacy Policy